Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05636527Recruiting

Further Evaluation of Safety and Performance of the NEXUS Aortic Arch Stent Graft System and the Custom-Made NEXUS Multibranch™ Aortic Arch Stent Graft System

Role: lead

NCT04471909Not ApplicableRecruiting

NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness

Role: lead

NCT03420066Completed

The NEXUS™ Compassionate Use Data Collection Study

Role: lead

NCT02087501Not ApplicableCompleted

HORIZON CE Pivotal Study to Treat Abdominal Aortic Aneurysm

Role: lead

NCT02365454Not ApplicableCompleted

NEXUS™ Aortic Arch Stent Graft System First In Man Study

Role: lead

NCT03208504Not ApplicableCompleted

The Single Branch NEXUS™ Clinical Study

Role: lead

All 6 trials loaded